Please login to the form below

Neupogen

This page shows the latest Neupogen news and features for those working in and with pharma, biotech and healthcare.

Novartis doubles down on biosimilars with Biocon alliance

Previous launches have included its Glatopa version of Teva’s multiple sclerosis drug Copaxone (glatiramer acetate) and Zarxio, a variant of Amgen’s Neupogen (filgrastim).

Latest news

Novartis takes biosimilar delay complaint to Supreme Court

Novartis is appealing an earlier ruling which ordered the company to delay launch of Zarxio, its version of Amgen's white blood cell stimulator Neupogen (filgrastim) and the first biosimilar to
Novartis claims first place for its biosimilar Enbrel in US

biosimilars business after the company got a green light for its Zarxio copy of Amgen's neutropenia therapy Neupogen (filgrastim).
Novartis gets FDA panel backing for biosimilar Enbrel

The GP2015 recommendation also puts Novartis on course for a second biosimilar approval in the US after its Zarxio product, a copy of Amgen's white blood cell stimulator Neupogen (filgrastim)
Sandoz files for approval of Neulasta biosimilar in Europe

The generic drug specialist - which also sells a biosimilar version of Amgen's short-acting GCSF product Neupogen (filgrastim) - said the Neulasta filing means it is now halfway to its objective
FDA panel recommends first biosimilar antibody for approval

The drug is also only the second biosimilar to be approved in the US after Novartis/Sandoz' Zarxio (filgrastim-sndz), which is a copy of Amgen's white cell stimulator Neupogen

More from news
Approximately 7 fully matching, plus 30 partially matching documents found.

Latest Intelligence

Biosimilars - the same, but different?

Neupogen (filgrastim).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales

This was preceded by a period as marketing director for the oncology business unit of Amgen, where he worked on such products as Neulasta, Neupogen and Vectibix.